HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Caspase blockade induces RIP3-mediated programmed necrosis in Toll-like receptor-activated microglia.

Abstract
Microglia are the resident immune cells in the central nervous system and key players against pathogens and injury. However, persistent microglial activation often exacerbates pathological damage and has been implicated in many neurological diseases. Despite their pivotal physiological and pathophysiological roles, how the survival and death of activated microglia is regulated remains poorly understood. We report here that microglia activated through Toll-like receptors (TLRs) undergo RIP1/RIP3-dependent programmed necrosis (necroptosis) when exposed to the pan caspase inhibitor zVAD-fmk. Although zVAD-fmk and the caspase-8 inhibitor IETD-fmk had no effect on unstimulated primary microglia, they markedly sensitized microglia to TLR1/2,3,4,7/8 ligands or TNF treatment, triggering programmed necrosis that was completely blocked by R1P1 kinase inhibitor necrostatin-1. Interestingly, necroptosis induced by TLR ligands and zVAD was restricted to microglial cells and was not observed in astrocytes, neurons or oligodendrocytes even though they are known to express certain TLRs. Deletion of genes encoding TNF or TNFR1 failed to prevent lipopolysaccharide- and poly(I:C)-induced microglial necroptosis, unveiling a TNF-independent programmed necrosis pathway in TLR3- and TLR4-activated microglia. Microglia from mice lacking functional TRIF were fully protected against TLR3/4 activation and zVAD-fmk-induced necrosis, and genetic deletion of rip3 also prevented microglia necroptosis. Activation of c-jun N-terminal kinase and generation of specific reactive oxygen species were downstream signaling events required for microglial cell death execution. Taken together, this study reveals a robust RIP3-dependent necroptosis signaling pathway in TLR-activated microglia upon caspase blockade and suggests that TLR signaling and programmed cell death pathways are closely linked in microglia, which could contribute to neuropathology and neuroinflammation when dysregulated.
AuthorsS J Kim, Jianrong Li
JournalCell death & disease (Cell Death Dis) Vol. 4 Pg. e716 ( 2013) ISSN: 2041-4889 [Electronic] England
PMID23846218 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Adaptor Proteins, Vesicular Transport
  • Caspase Inhibitors
  • Imidazoles
  • Indoles
  • Lipopolysaccharides
  • Oligopeptides
  • Reactive Oxygen Species
  • TICAM-1 protein, mouse
  • Toll-Like Receptors
  • Tumor Necrosis Factor-alpha
  • benzyloxycarbonyl-valyl-alanyl-aspartic acid
  • necrostatin-1
  • Ripk3 protein, mouse
  • Receptor-Interacting Protein Serine-Threonine Kinases
  • Ripk1 protein, mouse
  • JNK Mitogen-Activated Protein Kinases
  • Casp8 protein, mouse
  • Caspase 8
Topics
  • Adaptor Proteins, Vesicular Transport (metabolism)
  • Animals
  • Apoptosis
  • Astrocytes (drug effects, physiology)
  • Caspase 8 (metabolism)
  • Caspase Inhibitors (pharmacology)
  • Cell Survival
  • Cells, Cultured
  • Central Nervous System Diseases (immunology, therapy)
  • Imidazoles (pharmacology)
  • Indoles (pharmacology)
  • JNK Mitogen-Activated Protein Kinases (metabolism)
  • Lipopolysaccharides (pharmacology)
  • Mice
  • Mice, 129 Strain
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Microglia (drug effects, physiology)
  • Necrosis
  • Oligodendroglia (drug effects, physiology)
  • Oligopeptides (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species (metabolism)
  • Receptor-Interacting Protein Serine-Threonine Kinases (antagonists & inhibitors, metabolism)
  • Toll-Like Receptors (metabolism)
  • Tumor Necrosis Factor-alpha (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: